Read in and find out
View background literature as well as new publications by the AF-B-STEP consortium. Once new publications are available, we list them here. All IHI-funded publications are required to be Open Access, meaning the references on this page are linked directly to the full text publication.
-
Published: March 2026
Pre-procedural time spent in atrial fibrillation using intermittent ECG monitoring is associated with arrhythmia recurrence after ablation: the ISOLATION cohort study
Habib Z et al. (2026)Further readingEuropace, 28 (3), euag044.
Background Literature
-
Further reading
Becher N et al. (2024). Atrial fibrillation burden: a new outcome predictor and therapeutic target. European Heart Journal, 45: pp. 2824–2838.
-
Further reading
Doehner W et al. (2025). Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association. Europace, 27.
-
Further reading
Healey JS et al. (2024). Apixaban for stroke prevention in subclinical atrial fibrillation. New England Journal of Medicine, 390: pp. 107–117.
-
Further reading
Kirchhof P et al. (2023). Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine, 389: pp. 1167–1179.
-
Further reading
Kirchhof P et al. (2020). Early rhythm-control therapy in patients with atrial fibrillation. New England Journal of Medicine, 383 (14): pp. 1305–1316.
-
Further reading
Kirchhof P, Parwani AS, and Schenker N (2025). Does atrial fibrillation ablation prevent cardiovascular death, stroke, and heart failure events? Heart Rhythm, 22: pp. 2224–2226.
-
Further reading
Marrouche NF et al. and CASTLE-AF Investigators (2018). Catheter ablation for atrial fibrillation with heart failure. New England Journal of Medicine, 378 (5): pp. 417–427.
-
Further reading
Perez MV et al. (2019). Large-scale assessment of a smartwatch to identify atrial fibrillation. New England Journal of Medicine, 381 (20): pp. 1909–1917.
-
Further reading
Sanna T et al. and CRYSTAL AF Investigators (2014). Cryptogenic stroke and underlying atrial fibrillation. New England Journal of Medicine, 370 (26): pp. 2478–2486.
-
Further reading
Schnabel RB et al. (2015). 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. The Lancet, 386 (9989): pp. 154–162.
-
Further reading
Svennberg E et al. (2025). Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. Europace, 27.
-
Further reading
Svendsen JH et al. (2021). Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial. The Lancet, 398 (10310): pp. 1507–1516.
-
Further reading
Zeemering S et al. (2025). Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial. eClinicalMedicine, 88: 103457.
